Sign In
News Digest /
Lukas Schmidt
Author: Lukas Schmidt
04:48am, Friday, Oct 25, 2024
The proposed $8.5 billion merger between Tapestry (NYSE: TPR) and Capri Holdings (NYSE: CPRI) faces significant challenges after a US judge blocked it. The FTC fears reduced competition in luxury fashion. Capri shares fell nearly 50%, while Tapestry rose 12%.
07:50am, Thursday, Oct 24, 2024
Harley-Davidson (NYSE: HOG) has revised its revenue outlook, now predicting a 14-16% decline due to inflation and high borrowing costs. This shift signals broader challenges in consumer spending, prompting traders to closely monitor HOG's performance in the tumultuous market.
07:44am, Thursday, Oct 24, 2024
Beyond, Inc. (NYSE: BYON) shares fell 6% premarket after Q3 results missed expectations with a loss of $0.96 EPS and $311M revenue. Despite a 19% drop in orders, active customers rose 21%. Cost reductions and a strategic pivot may offer future growth potential.
07:41am, Thursday, Oct 24, 2024
S&P Global (NYSE: SPGI) surpassed Q3 earnings estimates, reporting $3.89 EPS and $3.58 billion revenue, lifting full-year guidance. The stock rose 1.5%, fueled by strong Ratings and Indices segments, signaling robust growth ahead.
07:32am, Thursday, Oct 24, 2024
American Airlines (NASDAQ: AAL) exceeded Q3 earnings expectations, reporting $0.30 EPS versus $0.16 forecast. Shares rose 1.25% as revenue hit $13.6 billion. The airline aims to reduce debt by $15 billion by 2025, presenting a strong investment opportunity.
07:28am, Thursday, Oct 24, 2024
CBRE Group (NYSE: CBRE) reported Q3 earnings of $1.20 per share, surpassing estimates and driving stock up 6.4%. Revenue soared 14.8% to $9.04B. The company raised its full-year earnings guidance, showcasing strong financials and growth prospects for investors.
07:44am, Wednesday, Oct 23, 2024
Boston Scientific (NYSE: BSX) shares rose over 1% in premarket trading after a strong Q3 earnings report, with EPS of $0.63 and revenue of $4.21 billion exceeding expectations. The company raised its 2024 EPS guidance, bolstering investor confidence.
06:06am, Tuesday, Oct 22, 2024
At a London tech conference, ASML's CEO, Christophe Fouquet, forecasted significant growth in 2026 despite potential challenges from U.S.-China tensions. He noted a slowdown in 2025 due to the electronics sector but emphasized the importance of watching ASML's upcoming earnings.
03:50am, Tuesday, Oct 22, 2024
Randstad (RAND.AS) reported Q3 profits slightly above expectations, with EBITA at €196M despite a 5.9% dip in quarterly revenue. The firm aims to enhance its digital presence by acquiring Zorgwerk for €323M, signaling strategic growth amid economic uncertainties.
03:47am, Tuesday, Oct 22, 2024
HSBC Holdings is restructuring under new CEO Georges Elhedery by merging commercial and investment banking to improve efficiency and profitability. Notably, Pam Kaur becomes the first female CFO. The bank's strategy aims for better service cross-selling while addressing operational challenges.
07:30am, Monday, Oct 21, 2024
Microsoft (NASDAQ: MSFT) unveils autonomous AI agents starting in November, aiming to streamline operations and enhance client engagement. Despite a recent stock decline, these innovations could transform AI investment returns and reshape business efficiency.
06:45am, Monday, Oct 21, 2024
UBS is divesting its 50% stake in Swisscard to American Express, shifting its focus post-Credit Suisse acquisition. This move aims to streamline operations, impacting cardholders in 2025, and signals UBS's strategic realignment in the banking sector.
06:37am, Monday, Oct 21, 2024
United Parcel Service (UPS) shares fell 1.7% after Barclays downgraded its rating due to concerns over profitability amid rising competition from Amazon and FedEx. The bank cut its price target to $120, signaling potential challenges ahead.
06:22am, Monday, Oct 21, 2024
Eli Lilly (NYSE: LLY) has filed lawsuits against online vendors and a medical spa for unauthorized sales of products claiming to contain tirzepatide, its weight-loss drug Zepbound. The legal actions aim to protect public health and consumer safety amid recent FDA developments.
